返回 Agenda
Session 2: Bridge from Evaluation to Access through Collaboration with Payers
Session Chair(s)
Virginia Acha, PhD, MSc
Global Lead, Global Regulatory Policy
MSD, United States
Session 2: Bridge from Evaluation to Access through Collaboration with Payers
Speaker(s)
Ansgar Hebborn, PhD, MBA
F. Hoffmann-La Roche AG, Switzerland
Head - Access Policy Affairs Europe
Work Towards Addressing the Evidence Gap
Michael Berntgen, PhD
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
Payer’s Perspective
Evert Jan van Lente, MS
AOK Bundesverband (Federal Insurer), Germany
Director EU-Affairs